无阻塞性冠状动脉疾病时的SPECT心肌缺血:微血管功能有创评估的贡献
本文通过四个代表性病例说明,在无阻塞性冠状动脉疾病且血流储备分数正常的患者中,SPECT心肌灌注显像所示的缺血可能与微血管功能障碍有关,后者可通过冠状动脉血流储备和微血管阻力指数进行有创评估。作者认为SPECT缺血应被视为硬性心脏事件的预后因素。
要点
- 无阻塞性冠状动脉疾病患者中,SPECT心肌缺血可能源于微血管功能障碍。
- 微血管功能障碍可通过冠状动脉血流储备和微血管阻力指数有创评估。
- SPECT缺血应被视为硬性心脏事件的预后因素。
核心结论
- SPECT心肌灌注显像所示的缺血可能源于无阻塞性冠状动脉疾病患者的微血管功能障碍,并应被视为硬性心脏事件的预后因素。
研究设计与样本
- 本文报告了四例无阻塞性冠状动脉疾病、血流储备分数正常且微血管阻力指数升高、冠状动脉血流储备降低的缺血患者代表性病例。
主要发现
- 四例患者均表现为无阻塞性冠状动脉疾病、血流储备分数正常,同时微血管阻力指数升高和冠状动脉血流储备降低。
- SPECT心肌灌注显像所示的灌注异常可能源于病理生理原因而非采集伪影。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coronary microvascular dysfunction has recently emerged as a major independent prognostic factor and can be invasively assessed by coronary flow reserve (CFR) and the index of microvascular resistance (IMR). The incremental prognostic value of myocardial ischemia from SPECT myocardial perfusion imaging (MPI) over clinical characteristics, cardiac risk factors, and stress test data for the prediction of hard cardiac events (myocardial infarction and cardiac death) has been well demonstrated over the last two decades regardless of the absence or presence of epicardial CAD. Recently developed semi-conductor, cardiac-dedicated cameras allow for decreased acquisition times and systematic procubitus and decubitus acquisitions thereby limiting the occurrence of false positives historically attributable to artefactual motion, attenuation, and digestive artifacts. It is therefore likely that pathophysiological causes rather than acquisition artifacts might underlie SPECT perfusion abnormalities. Here, we report four representative examples of patients presenting with ischemia in the setting of no obstructive CAD and normal fractional flow reserve together with elevated IMR and low CFR. The results indicate that ischemia from SPECT MPI could result from microvascular dysfunction in patients without obstructive CAD and should be considered as a prognostic factor for hard cardiac events.
引用
- Djaïleb L, Riou L, Piliero N, et al. SPECT myocardial ischemia in the absence of obstructive CAD: Contribution of the invasive assessment of microvascular dysfunction. J Nucl Cardiol. 2017. PMID: 29209950. doi:10.1007/s12350-017-1135-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。